Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
61.82
-1.33 (-2.11%)
At close: Jul 17, 2026, 4:00 PM EDT
61.60
-0.22 (-0.35%)
After-hours: Jul 17, 2026, 7:32 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $24.53 billion as of July 17, 2026. Its market cap has increased by 97.83% in one year.
Market Cap
24.53B
Enterprise Value
18.36B
1-Year Change
97.83%
Ranking
Category
Stock Price
$61.82
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $24.53B, an increase of 300.91%. That is a compound annual growth rate of 20.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 24.53B | 112.88% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 38.71B |
| Alnylam Pharmaceuticals | 37.75B |
| BeOne Medicines AG | 34.62B |
| Royalty Pharma | 31.78B |
| Roivant Sciences | 24.87B |
| Insmed | 23.84B |
| BioNTech SE | 22.83B |
| Incyte | 22.78B |